Public pages use no advertising trackers. The secure portal uses an essential session cookie and the service providers described in our privacy policy.

Skip to main content

· Court ruling

Pattison v. Teladoc Health, Inc.

U.S. District Court for the Southern District of New York, No. 7:23-cv-11305 (NSR), ECF No. 38

For plaintiffsMotion to dismiss denied as to the Wiretap Act claim and seven other claims, and granted without prejudice as to four claims

Primary source: Opinion and order. Checked on November 10, 2026.

A New York federal court let a Wiretap Act claim against Teladoc proceed, holding alleged interception of users' health information to disclose it without authorization for marketing, an act HIPAA punishes, invokes the crime-tort exception.

What happened

Eight users of Teladoc Health's telehealth platform, which connects users to doctors, therapists, specialists and dietitians, sued on behalf of a proposed class under the federal Wiretap Act and New York, Florida and California law. (ECF No. 38 at 1-2.)

The amended complaint alleged that Teladoc installed the Facebook Pixel and the Conversions API on its website, my.teladoc.com, and that these facilitated the dissemination of the health and personal information users entered on the platform, such as names, contact details, health conditions, diagnoses, prescriptions and insurance information, to third parties like Facebook without the users' consent. (ECF No. 38 at 2.)

Many plaintiffs alleged that after using the platform they saw Facebook advertisements tailored to their medical conditions. The complaint alleged that Teladoc used the tracking technology knowing the information would be sent to Facebook, to improve its advertising and bolster its revenues. (ECF No. 38 at 2-3.)

The court took the amended complaint's allegations as true and construed them in the light most favorable to the plaintiffs, as it must on a motion to dismiss. (ECF No. 38 at 1, 3-4.)

What the court held

  1. Following Gay v. Garnet Health, an earlier decision by the same judge on parallel facts, the court held that the plaintiffs plausibly alleged that Teladoc's purpose at the time of interception was to commit a separate act punishable under 42 U.S.C. § 1320d-6, knowingly disclosing their health and personal information without authorization for marketing, which invokes the crime-tort exception to the one-party consent rule. (ECF No. 38 at 4-6)

    Such allegations are enough to invoke the criminal-tortious exemption to the one-party consent rule of the ECPA, and, as a result, allow Plaintiffs to bring forth an ECPA claim.

    ECF No. 38 at 5
  2. The court held this result consistent with the Second Circuit's decision in Caro v. Weintraub, because the plaintiffs pleaded that the criminal act was the separate, secondary act of disseminating their information through the Pixel and Conversions API to third parties such as Facebook and Google, not the interception itself. (ECF No. 38 at 6-7)

    Plaintiffs are not pleading that the mere act of interception is the criminal or tortious act

    ECF No. 38 at 6
  3. The breach of confidence claim survived. The court rejected Teladoc's argument that it is a technology platform rather than a doctor or hospital, holding, on the amended complaint's description of its services, that it functions as a healthcare provider and owes a duty of confidentiality, which the court tied to HIPAA obligations. (ECF No. 38 at 8-9)

    Defendant, in other words, functions as a healthcare provider such as a hospital, which courts have already concluded can be subject to a tort claim of breach of confidentiality.

    ECF No. 38 at 9
  4. The New York General Business Law § 349 claim survived. The alleged gap between Teladoc's privacy policy and its conduct was enough at this stage to allege materially misleading conduct, and a plaintiff's allegation that she would not have provided her information or bought the services had she known was enough to plead injury. (ECF No. 38 at 10-11)

    This is enough for the purposes of pleading injury at the motion to dismiss stage.

    ECF No. 38 at 11
  5. The Florida Security of Communications Act claim survived because the plaintiffs alleged the interception of their medical information, which is the substance of their communications, and not merely the tracking of their movements on the website. (ECF No. 38 at 11-12)

    Plaintiffs are clearly pleading that Defendant intercepted the “substance, purport, or meaning” of the communication itself

    ECF No. 38 at 12
  6. The California Invasion of Privacy Act claim survived because the court applied the same analysis as under the federal Wiretap Act. The California Confidentiality of Medical Information Act claim survived because the alleged unauthorized disclosure that stated a HIPAA violation also stated a claim under that statute. The Unfair Competition Law claim survived on alleged benefit-of-the-bargain losses and diminished value of private data, and the Consumers Legal Remedies Act claim on alleged benefit-of-the-bargain harm. (ECF No. 38 at 12-14)

  7. The negligence, breach of implied contract, constructive bailment and unjust enrichment claims were dismissed without prejudice: the complaint identified no negligent conduct, the parties intended to be bound by written policies, the plaintiffs kept control over their information, and the plaintiffs withdrew the unjust enrichment claim. (ECF No. 38 at 7-10)

  8. The plaintiffs were given until July 30, 2025 to file a second amended complaint, and the order provided that claims dismissed without prejudice would be deemed dismissed with prejudice if none was filed. (ECF No. 38 at 15)

What it did not decide

  • Whether Teladoc was in fact a party to the communications; the court applied the crime-tort exception to the one-party consent rule without separately discussing party status (ECF No. 38 at 4-7).
  • Whether a profit or advertising motive defeats the exception; the opinion treats the alleged marketing purpose as part of the HIPAA crime and does not address a separate profit-motive defense (ECF No. 38 at 5-6).
  • Whether the information was in fact individually identifiable health information, or whether Teladoc in fact acted knowingly; the court relied on the amended complaint's allegations (ECF No. 38 at 1, 5-6).
  • Article III standing, class certification and statutory damages under 18 U.S.C. § 2520; the opinion does not discuss them.

The tracking involved

Tools

  • Facebook Pixel (Meta Pixel)
  • Facebook Conversions API

Data

  • names, dates of birth, email and home addresses and phone numbers
  • health conditions, diagnoses and treatment information
  • prescription and medication information
  • health insurance information

How it bears on website tracking claims

Supports: strengthens a website tracking claim on this issue. Limits: narrows or defeats a website tracking claim on this issue. Context: bears on the issue without deciding it either way.

  • Supports: Crime-tort exception

    Whether a communication was intercepted for the purpose of a criminal or tortious act, which removes the party exception.

    At the pleading stage, the court accepted the alleged disclosure of users' health information for marketing, an act punishable under 42 U.S.C. § 1320d-6, as the separate act the exception requires, relying on Gay v. Garnet Health and other Pixel decisions such as Kane v. University of Rochester and Cooper v. Mount Sinai Health System. It is a ruling on the pleadings by a district court, it rests on HIPAA as the predicate, and it does not address the argument that a commercial motive rules out a criminal or tortious purpose.

    All tracker entries on this issue

  • Supports: HIPAA

    How HIPAA, its criminal provision at 42 U.S.C. § 1320d-6 and HHS guidance bear on tracking.

    The court treated knowing disclosure of health and personal information without authorization for marketing as punishable under 42 U.S.C. § 1320d-6, and in the breach of confidence discussion it described Teladoc, as a medical services provider, as subject to HIPAA obligations. It did not separately analyze whether each type of data is individually identifiable health information or whether Teladoc acted knowingly.

    All tracker entries on this issue

  • Context: Party exception

    Whether the website, as a party to the visit, could consent to the tracking under 18 U.S.C. § 2511(2)(d).

    The court started from the rule that, where the defendant consented to the interception, a plaintiff must allege interception for the purpose of a criminal or tortious act independent of the recording, and it decided the claim on that exception. The opinion does not discuss whether Teladoc was in fact a party.

    All tracker entries on this issue

  • Supports: State wiretap laws

    State interception statutes, such as California Penal Code § 631 and the Washington Privacy Act.

    The Florida Security of Communications Act claim survived because the alleged medical information was the contents of the communications, and the California Invasion of Privacy Act claim survived because the court applied the same analysis as under the federal Wiretap Act. The opinion does not say which section of the California statute was pleaded.

    All tracker entries on this issue

  • Supports: Contents

    Whether what was sent, such as page addresses, searches and clicks, counts as the contents of a communication.

    In the Florida discussion, the court held that the plaintiffs adequately alleged interception of the substance, purport or meaning of their communications, namely medical information such as their conditions, which allegedly led to condition-specific ads. It agreed that the Florida statute does not cover the mere tracking of a visitor's movements on a website, but found that the plaintiffs alleged more than that.

    All tracker entries on this issue

  • Supports: Consumer protection

    Deception and unfair practice claims, such as under the FTC Act and N.Y. General Business Law § 349.

    The New York General Business Law § 349 claim survived on the alleged gap between Teladoc's privacy policy and its transmissions, with injury pleaded through the allegation that a plaintiff would not have provided her information or bought the services had she known. California's Unfair Competition Law and Consumers Legal Remedies Act claims survived on benefit-of-the-bargain theories, and the Unfair Competition Law claim also on the diminished value of private data.

    All tracker entries on this issue

  • Supports: State privacy laws

    Other state privacy statutes and claims, such as medical information and health records acts and the CCPA.

    The California Confidentiality of Medical Information Act claim survived because the alleged unauthorized disclosure that stated a HIPAA violation also stated a claim under that statute. The common-law breach of confidence claim survived as well, on the view that Teladoc functions as a healthcare provider.

    All tracker entries on this issue

Arguments it addresses

The website was a party to the communication
The court applied the one-party consent framework and held that the alleged intent to disclose health information in violation of HIPAA brought the claim within the crime-tort exception at the pleading stage (ECF No. 38 at 4-7).
The interception and the alleged HIPAA violation are the same act
The court held that the plaintiffs pleaded a separate, secondary act of disseminating their information to third parties, so Caro did not require dismissal (ECF No. 38 at 6-7).
The purpose was advertising, not a crime
The opinion does not address a separate profit-motive defense; it treated the alleged purpose of disclosing information without authorization for marketing as the HIPAA crime itself (ECF No. 38 at 5-6).
The company is a technology platform, not a doctor or hospital
The court rejected this for the breach of confidence claim, holding that Teladoc functions as a healthcare provider (ECF No. 38 at 8-9).
Only movements on the website were tracked, not contents
For the Florida claim, the court held that the alleged interception of medical information was the substance of the communication (ECF No. 38 at 11-12).
No injury
For the General Business Law § 349 claim, the court held that an allegation that a plaintiff would not have bought the services had she known was enough at the pleading stage (ECF No. 38 at 11).

For a company that received a letter

  • This was a ruling on the pleadings: the court accepted the amended complaint's allegations as true and made no finding that Teladoc acted unlawfully.
  • The Wiretap Act holding rested on HIPAA as the predicate crime and on allegations about what users entered on a telehealth platform, including conditions, prescriptions and insurance information.
  • The court followed Gay v. Garnet Health, an earlier decision by the same judge, and did not address a separate commercial-motive defense.
  • The four dismissed claims were not repleaded, and the case went on to an answer and discovery on the rest.

What to check on your own site

  • Check whether tracking tags or server-side connections run on pages where users enter conditions, prescriptions or insurance information.
  • Check what event data your site sends to advertising platforms after a user submits health information.
  • Check whether what your privacy policy says about sharing matches what your tags and server-side connections send.

Later history

The plaintiffs filed a notice of non-amendment on July 2, 2025 (ECF No. 39), and the docket shows no second amended complaint, so under the order's terms the four dismissed claims are deemed dismissed with prejudice. Teladoc answered the amended complaint on August 20, 2025, denying the allegations except as expressly admitted and denying liability (ECF No. 42). The case is in discovery: an order of July 20, 2026 extended fact discovery to March 19, 2027 and expert depositions to August 6, 2027 (ECF No. 67), and the case was still pending as of November 10, 2026.

September 16, 2024 · Court rulingGay v. Garnet Health (S.D.N.Y. 2024)Mixed rulingPatients' Wiretap Act claim against their hospital survived dismissal because they plausibly alleged it intended to send their identifiable health information to Facebook without consent for commercial purposes, a disclosure HIPAA makes a crime.March 19, 2024 · Court rulingKane v. University of Rochester (W.D.N.Y. 2024)Mixed rulingA Schedule an Appointment click on a physician's profile, sent to Facebook with the user's Facebook ID, was plausibly individually identifiable health information, so a Wiretap Act claim proceeded under the crime-tort exception.July 30, 2024 · Court rulingCooper v. Mount Sinai Health System (S.D.N.Y. 2024)For plaintiffsA federal court let a Wiretap Act claim over a health system's Meta Pixel proceed, holding that alleged disclosure of identifiable patient health information for commercial ends plausibly invoked the crime-tort exception through HIPAA.February 21, 2025 · Court rulingStein v. Edward-Elmhurst Health (N.D. Ill. 2025)Mixed rulingAn Illinois federal court held that a health care provider's alleged disclosure of patient information to Facebook in violation of HIPAA satisfies the crime-tort exception, even if done for profit; the question is on appeal.November 14, 2024 · Court rulingCastillo v. Costco Wholesale (W.D. Wash. 2024)Mixed rulingRuling on the pleadings, a Seattle federal court held pharmacy customers' prescription searches sent to Meta were contents and a financial motive does not defeat the crime-tort exception, but dismissed the Washington Privacy Act claim.September 22, 2025 · Court rulingSweat v. Houston Methodist Hospital (S.D. Tex. 2025)For defendantsOn summary judgment, a Texas federal court held a hospital's Facebook Pixel use fell outside the crime-tort exception because the evidence showed it did not know it was disclosing identifiable health information.

Published by Privacy Resolve from public records. It does not cover our own matters.

General information only, not legal advice, and not a substitute for the advice of an attorney. Laws, deadlines, defenses and outcomes vary by jurisdiction and facts.